National News
NAFDAC halts Artemether/Lumefantrine registration

The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
News2 days ago
Zamfara mourns as Emir of Gusau, Alhaji Ibrahim Bello, dies at 71
-
NUJ FCT1 day ago
NUJ FCT Chair, Grace Ike, appreciates members for successful 2025 Press Week
-
Sports2 days ago
WAFCON Final: Tinubu approves full bonus payments for Super Falcons
-
Council News2 days ago
NUJ FCT inaugurates press clubs in Secondary Schools to mentor future Journalists
-
Metro2 days ago
Gunmen kill Seven in Imo late-night attack
-
News2 days ago
Lagos ranked among World’s top nightlife cities, secures second spot in Africa
-
NUJ FCT1 day ago
NUJ FCT mourns veteran journalist Leon Usigbe
-
World News2 days ago
France defends move to recognise Palestinian State despite criticism